Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Active fluid management with BIA monitoring is a clinical therapeutic protocol developed by Seoul St. Mary's Hospital to optimize the hydration status of postoperative patients in the Surgical Intensive Care Unit (SICU). The strategy utilizes real-time Bioelectrical Impedance Analysis (BIA) to monitor the extracellular water (ECW) ratio, targeting a specific range of 0.390 to 0.406. Patients identified as dehydrated (ECW ratio < 0.390) receive intravenous bolus infusions of PlasmaLyte, a balanced crystalloid solution used for volume expansion. Patients identified as overhydrated (ECW ratio > 0.406) are administered furosemide, a loop diuretic that inhibits the NKCC2 symporter in the thick ascending limb of the loop of Henle. This guided approach aims to maintain patients within an ideal fluid status range to improve clinical outcomes and prevent complications associated with fluid imbalance in the acute postoperative phase.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Active fluid management with BIA monitoring.